Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Current Features

Advertisement

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Current Features

Uncovering the Supply Strategies Shaping More Patient centric Drug Development

Patients. Subjects. Participants. However we define them, the role they play in bringing new drugs to market is unquestionable. As such, drug developers the world ov...
Continue Reading →
Current Features

The Role of Ergonomic Studies and Automated Solutions in Nasal Drug Product Development

The development of orally inhaled and nasal drug products (OINDPs) presents significant challenges, with failure rates of 70% and higher. This high failure rate stem...
Continue Reading →
Current Features

Q & A with Sarah Bunyan: Understanding and Anticipating Regulation in the pMDI Space

As sustainability pressures drive innovation in pressurised Metered Dose Inhalers (pMDIs), the regulatory landscape must shift to accommodate new low carbon technolo...
Continue Reading →
Current Features

Advancing Nasal Protection: Healthcare Innovations Beyond COVID-19

The Evolution of Nasal Protection Solutions The global scientific community continues to advance research on COVID-19 and its long-term effects, commonly referred to...
Continue Reading →
Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025

Company Profiles

Emerson